This case does not need a heroic
rerating. The setup works if Amprius turns technical credibility into repeat shipments across drones, defense, lightweight aviation, and adjacent robotics, while keeping
gross margins premium enough to stay above commodity-cell peers. I expect some valuation normalization as the story matures, but not a collapse, because endurance,
qualification, and trusted regional supply should still matter in its niche.